Anavex Life Sciences (AVXL)

Anavex Life Sciences (AVXL) Financial Statements


Anavex Life Sciences Financial Overview

Anavex Life Sciences's market cap is currently ―. The company's EPS TTM is $-0.496; its P/E ratio is -7.82; Anavex Life Sciences is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -11.29M$ -12.17M$ -13.07M$ -14.52M$ -15.02M
EBITDA$ -11.29M$ -12.17M$ -13.07M$ -14.52M$ -15.02M
Net Income Common Stockholders$ -8.62M$ -10.15M$ -11.28M$ -13.11M$ -12.97M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 143.76M$ 151.02M$ 154.82M$ 153.47M$ 143.62M
Total Assets$ 148.07M$ 154.39M$ 157.81M$ 159.19M$ 148.37M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -143.76M$ -151.02M$ -154.82M$ -153.47M$ -143.62M
Total Liabilities$ 12.49M$ 12.53M$ 11.06M$ 14.02M$ 13.25M
Stockholders Equity$ 135.57M$ 141.85M$ 146.75M$ 145.17M$ 135.12M
Cash Flow-
Free Cash Flow$ -7.32M$ -5.85M$ -7.65M$ -8.49M$ -5.79M
Operating Cash Flow$ -7.32M$ -5.85M$ -7.65M$ -8.49M$ -5.79M
Investing Cash Flow-----
Financing Cash Flow$ 59.00K$ 2.06M$ 9.00M$ 18.33M$ 258.24K
Currency in USD

Anavex Life Sciences Earnings and Revenue History

Anavex Life Sciences Debt to Assets

Anavex Life Sciences Cash Flow

Anavex Life Sciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis